Skip to main content
SpringerLink
Log in

Chemotherapie, Operation und Bestrahlung

Multimodale Therapiekonzepte beim malignen Pleuramesotheliom

  • fortbildung
  • Published:
Pneumo News Aims and scope

Das maligne Pleuramesotheliom ist ein seltener, aggressiv wachsender Tumor der Pleura, der häufig mit einer Asbestexposition assoziiert ist. Die überwiegend männlichen Patienten haben oft Begleiterkrankungen, wodurch das Behandlungsmanagement erschwert wird. Es gibt mehrere multimodale Therapiekonzepte, die sich vor allem hinsichtlich des Umfangs und der Art einer chirurgischen Therapie unterscheiden, sofern sie dem Tumorstadium entsprechend indiziert ist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2

Literatur

  1. Opitz I. Management of malignant pleural mesothelioma-The European experience. J Thorac Dis. 2014;6 (Suppl 2):S238-52. https://doi.org/10.3978/j.issn.2072-1439.2014.05.03

    Google Scholar 

  2. Ladanyi M, Zauderer MG, Krug LM et al. New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Clin Cancer Res. 2012;18(17):4485–90. https://doi.org/10.1158/1078-0432.CCR-11-2375

    Article  CAS  Google Scholar 

  3. Scherpereel A, Astoul P, Baas P et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35(3):479–95. https://doi.org/10.1183/09031936.00063109

    Article  CAS  Google Scholar 

  4. Van Schil PE, Opitz I, Weder W et al. Multimodal management of malignant pleural mesothelioma: where are we today? Eur Respir J. 2014;44(3):754–64. https://doi.org/10.1183/09031936.00207213

    Article  Google Scholar 

  5. Carbone M, Ly BH, Dodson RF et al. Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol. 2012;227(1):44–58. https://doi.org/10.1002/jcp.22724

    Article  CAS  Google Scholar 

  6. Travis WD, Brambilla E, Nicholson AG et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243–60. https://doi.org/10.1097/JTO.0000000000000630

    Article  Google Scholar 

  7. Kitajima K, Doi H, Kuribayashi K et al. Prognostic value of pretreatment volume-based quantitative (18)F-FDG PET/CT parameters in patients with malignant pleural mesothelioma. Eur J Radiol. 2017;86:176–83. https://doi.org/10.1016/j.ejrad.2016.11.019

    Article  Google Scholar 

  8. Sugarbaker DJ, Gill RR, Yeap BY et al. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg. 2013;145(4):955–63. https://doi.org/10.1016/j.jtcvs.2012.12.037

    Article  CAS  Google Scholar 

  9. Cao C, Tian D, Park J et al. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer. 2014;83(2):240–5. https://doi.org/10.1016/j.lungcan.2013.11.026

    Article  Google Scholar 

  10. Schwartz RM, Watson A, Wolf A et al. The impact of surgical approach on quality of life for pleural malignant mesothelioma. Ann Transl Med. 2017;5(11):230. https://doi.org/10.21037/atm.2017.03.41

    Article  Google Scholar 

  11. Hasegawa S. Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. 2014;62(9):516–21. https://doi.org/10.1007/s11748-014-0389-7

    Article  Google Scholar 

  12. Taioli E, Wolf AS, Flores RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015;99(2):472–80. https://doi.org/10.1016/j.athoracsur.2014.09.056

    Article  Google Scholar 

  13. Sugarbaker DJ. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol. 2006;1(2):175–6

    Article  Google Scholar 

  14. Raskin J, Surmont V, Cornelissen R et al. A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205). Transl Lung Cancer Res. 2018;7(5):593–8. https://doi.org/10.21037/tlcr.2018.05.07

    Article  Google Scholar 

  15. Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21(14):2636–44. https://doi.org/10.1200/JCO.2003.11.136

    Article  CAS  Google Scholar 

  16. van Meerbeeck JP, Gaafar R, Manegold C et al et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol. 2005;23(28):6881–9. https://doi.org/10.1200/JCO.20005.14.589

    Article  CAS  Google Scholar 

  17. Zalcman G, Mazieres J, Margery J et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet. 2016;387(10026):1405–14. https://doi.org/10.1016/S0140-6736(15)01238-6

    Article  CAS  Google Scholar 

  18. Mancuso MR, Neal JW. Novel systemic therapy against malignant pleural mesothelioma. Transl Lung Cancer Res. 2017;6(3):295–314. https://doi.org/10.21037/tlcr.2017.06.01

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chirurgische Abteilung, Thoraxklinik Heidelberg, Universitätsklinikum Heidelberg, Röntgenstraße 1, 69126, Heidelberg, Deutschland

    Laura V. Klotz,  Florian Eichhorn,  Hauke Winter &  Martin E. Eichhorn

Authors
  1. Laura V. Klotz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florian Eichhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hauke Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martin E. Eichhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura V. Klotz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klotz, L.V., Eichhorn, F., Winter, H. et al. Multimodale Therapiekonzepte beim malignen Pleuramesotheliom. Pneumo News 11, 23–28 (2019). https://doi.org/10.1007/s15033-019-1153-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-019-1153-6

Search

Navigation